These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17516166)

  • 1. Cardioprotective actions of peptide hormones in myocardial ischemia.
    Burley DS; Hamid SA; Baxter GF
    Heart Fail Rev; 2007 Dec; 12(3-4):279-91. PubMed ID: 17516166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute actions of natriuretic peptides in coronary vasculature and ischaemic myocardium.
    Rautureau Y; Baxter GF
    Curr Pharm Des; 2004; 10(20):2477-82. PubMed ID: 15320757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides and myocardial ischaemia.
    Baxter GF
    Basic Res Cardiol; 2004 Mar; 99(2):90-3. PubMed ID: 14963667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardioprotective effect of dual metallopeptidase inhibition: respective roles of endogenous kinins and natriuretic peptides.
    Dumoulin MJ; Adam A; Burnett J; Heublein D; Yamaguchi N; Lamontagne D
    Can J Physiol Pharmacol; 2005 Feb; 83(2):166-73. PubMed ID: 15791290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autocrine and paracrine actions of natriuretic peptides in the heart.
    D'Souza SP; Davis M; Baxter GF
    Pharmacol Ther; 2004 Feb; 101(2):113-29. PubMed ID: 14761702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction.
    Arakawa K; Himeno H; Kirigaya J; Otomo F; Matsushita K; Nakahashi H; Shimizu S; Nitta M; Takamizawa T; Yano H; Endo M; Kanna M; Kimura K; Umemura S
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):62-70. PubMed ID: 25609593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenomedullin limits reperfusion injury in experimental myocardial infarction.
    Hamid SA; Baxter GF
    Basic Res Cardiol; 2005 Sep; 100(5):387-96. PubMed ID: 16010601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides as therapy in cardiac ischaemia/reperfusion.
    Kousholt BS
    Dan Med J; 2012 Jun; 59(6):B4469. PubMed ID: 22677252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection.
    Hausenloy DJ; Yellon DM
    Heart Fail Rev; 2007 Dec; 12(3-4):217-34. PubMed ID: 17541822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
    Hobbs A; Foster P; Prescott C; Scotland R; Ahluwalia A
    Circulation; 2004 Sep; 110(10):1231-5. PubMed ID: 15337698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protective actions of nitric oxide donors after myocardial ischemia and reperfusion.
    Lefer DJ
    New Horiz; 1995 Feb; 3(1):105-12. PubMed ID: 7704591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction.
    Hamid SA; Baxter GF
    Pharmacol Ther; 2005 Feb; 105(2):95-112. PubMed ID: 15670621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protection in man--from research concept to clinical practice.
    Cokkinos DV; Pantos C
    Heart Fail Rev; 2007 Dec; 12(3-4):345-62. PubMed ID: 17541821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes and cardiac protective effects of adrenomedullin during myocardial ischemia-reperfusion period].
    Cao J; Zhang J; Wang X
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):261-4. PubMed ID: 11798767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin infusion attenuates myocardial ischemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway.
    Okumura H; Nagaya N; Itoh T; Okano I; Hino J; Mori K; Tsukamoto Y; Ishibashi-Ueda H; Miwa S; Tambara K; Toyokuni S; Yutani C; Kangawa K
    Circulation; 2004 Jan; 109(2):242-8. PubMed ID: 14691041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocrine function of the heart.
    McGrath MF; de Bold ML; de Bold AJ
    Trends Endocrinol Metab; 2005 Dec; 16(10):469-77. PubMed ID: 16269246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adaptation of myocardium to ischemia. The early phase of ischemic preconditioning].
    Maslov LN; Lishmanov IuB; Solenkova NV
    Usp Fiziol Nauk; 2006; 37(3):25-41. PubMed ID: 17022466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natriuretic peptides.
    Baxter GF
    Basic Res Cardiol; 2004 Mar; 99(2):71-5. PubMed ID: 14963664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular forms of adrenomedullin in pericardial fluid and plasma in patients with ischaemic heart disease.
    Nishikimi T; Shibasaki I; Iida H; Asakawa H; Matsushita Y; Mori H; Mochizuki Y; Okamura Y; Horinaka S; Kangawa K; Shimada K; Matsuoka H
    Clin Sci (Lond); 2002 Jun; 102(6):669-77. PubMed ID: 12049623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.